How did Regeneron's revenue and expenses trend in Q4 2024?
4/14/2025 03:39am
Aime
Regeneron's revenue for Q4 2024 was $515 million, while the R&D expenses were $1.41 billion1. This indicates that the company's focus on research and development was significant during the quarter, potentially paving the way for future growth and innovation.
1/2
REGN Revenue By Business
Source:
1.
REGN Revenue by Business, R&D Expenses, Sales and Marketing Expenses in Q4 2024
more
less
Explore
Screener
Best looking stocks that are MACD Golden Cross
Analysis
What is the trend of APOG's stock price?
Learn
What is a smart contract and give examples
Wiki
For diabetes, what foods or drink are good to consume?